Literature DB >> 5004340

Glibenclamide: a review.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5004340     DOI: 10.2165/00003495-197101020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  35 in total

1.  Beta-adrenergic stimulation and insulin release in dogs following HB 419.

Authors:  O V Sirek; M Vigas; A Niki; H Niki; A Sirek
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

2.  [Stimulation of insulin secretion in vitro by a new, highly-active antidiabetic].

Authors:  H Schwarz; J Ammon; J E Yeboah; H E Hildebrandt; E F Pfeiffer
Journal:  Diabetologia       Date:  1968-01       Impact factor: 10.122

3.  Preliminary clinical evaluation of glybenclamide in treatment of diabetes mellitus.

Authors:  B F Johnson; C K Bhatia; W J Rzeszotarski; F W Wolff
Journal:  Diabetes       Date:  1970-08       Impact factor: 9.461

4.  [Light-optic morphological studies on the B-cells of the islets of langerhans after administration of HB 419].

Authors:  A Bänder; W Pfaff; G Schesmer
Journal:  Arzneimittelforschung       Date:  1969-08

5.  [Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].

Authors:  A Hasselblatt; U Panten; W Poser
Journal:  Arzneimittelforschung       Date:  1969-08

6.  [Resorption, distribution and excretion after administration of 14C-labelled HB 419 in rabbits, rats and dogs].

Authors:  H M Kellner; O Christ; W Rupp; W Heptner
Journal:  Arzneimittelforschung       Date:  1969-08

7.  [Pharmacology of HB 419, a new strongly effective oral antidiabetic].

Authors:  A Bänder; W Pfaff; F H Schmidt; H Stork; H G Schröder
Journal:  Arzneimittelforschung       Date:  1969-08

8.  [Toxicological studies of N-4-2-(5-chloro-2-methoxybenzamido)-ethyl-phenylsulfonyl-n'-cyclohexylurea (HB 419)].

Authors:  K Mizukami; M Miyamoto; S Hayashi; T Kobayashi; M Sakurai; T Sakaguchi
Journal:  Arzneimittelforschung       Date:  1969-08

9.  [Causes and prevention of hypoglycemia due to glibenclamide].

Authors:  H Gutsche; W Höpker; G Boenicke
Journal:  Med Welt       Date:  1969-08-30

10.  Clinical and metabolic study in diabetic patients treated with glibenclamide.

Authors:  J Anderson; R Coulson; B D Grassick; B A Morris; W D Thomas; R W Tomlihson; F Woodroffe
Journal:  Br Med J       Date:  1970-06-06
View more
  3 in total

Review 1.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 3.  BIIB093 (intravenous glibenclamide) for the prevention of severe cerebral edema.

Authors:  Daniel W Griepp; Jason Lee; Christina M Moawad; Cyrus Davati; Juliana Runnels; Brian Fiani
Journal:  Surg Neurol Int       Date:  2021-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.